Schedule 13G ownership disclosure
Edgewise Therapeutics Inc
Common Stock · CUSIP: 28036F105
Event date: 2025-06-30
- Filing-level shares
- 5,503,349
- Percent of class
- 5.2%
- JANUS HENDERSON GROUP PLC
Shares: 5,503,349 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000244
- Form type
- SCHEDULE 13G/A
- Filer
- Edgewise Therapeutics, Inc.
- CIK
- CIK 1710072
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership